6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Lung Diseases, Obstructive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MacNee, W; Rahman, I; Skwarska, E | 1 |
1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Aged; Antioxidants; Bronchodilator Agents; Chromans; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Ipratropium; Lipid Peroxidation; Lung Diseases, Obstructive; Male; Oxidants; Oxidative Stress; Prednisolone | 1997 |